Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

39 results about "Coronary arterial tree" patented technology

Angiographic image acquisition system and method with automatic shutter adaptation for yielding a reduced field of view covering a segmented target structure or lesion for decreasing X-radiation dose in minimally invasive X-ray-guided interventions

The present invention refers to an angiographic image acquisition system and method which can beneficially be used in the scope of minimally invasive image-guided interventions. In particular, the present invention relates to a system and method for graphically visualizing a pre-interventionally virtual 3D representation of a patient's coronary artery tree's vessel segments in a region of interest of a patient's cardiovascular system to be three-dimensionally reconstructed. Optionally, this 3D representation can then be fused with an intraoperatively acquired fluoroscopic 2D live image of an interventional tool. According to the present invention, said method comprises the steps of subjecting the image data set of the 3D representation associated with the precalculated optimal viewing angle to a 3D segmentation algorithm (S4) in order to find the contours of a target structure or lesion to be examined and interventionally treated within a region of interest and automatically adjusting (S5) a collimator wedge position and / or aperture of a shutter mechanism used for collimating an X-ray beam emitted by an X-ray source of a C-arm-based 3D rotational angiography device or rotational gantry-based CT imaging system to which the patient is exposed during an image-guided radiographic examination procedure based on data obtained as a result of said segmentation which indicate the contour and size of said target structure or lesion. The aim is to reduce the region of interest to a field of view that covers said target structure or lesion together with a user-definable portion of the surrounding vasculature.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV

Method and device for obtaining average blood flow and flow rate at outlet of coronary artery, and system

The application provides a method and device for obtaining average blood flow and flow rate at an outlet of a coronary artery, and a system. The method for obtaining the average blood flow at the outlet of the coronary artery in a cardiac cycle comprises the following steps of in one cardiac cycle, according to the volume of cardiac muscles, obtaining the total blood flow of an inlet of the coronary artery; extracting the blood vessel diameter of each of all the outlets of a corona arterial tree; and according to the total blood flow at the inlet of the coronary artery and the blood vessel diameter of the outlet of the coronary artery, obtaining the average blood flow at the outlet of the coronary artery in the cardiac cycle. The method disclosed by the application is a new non-invasive detection means, measuring the blood flow does not need to rely on a coronary artery ultrasonic technique, and according to the total blood flow at the inlet of the coronary artery and the blood vesseldiameter at the outlet, the average blood flow at the outlet of the coronary artery in one cardiac cycle can be obtained, so that the operation is easy, fine structure images can be distinguished, andthe measuring is more accurate.
Owner:SUZHOU RAINMED MEDICAL TECH CO LTD

Application of Morindae officinalis oligosaccharide 6 glycan in preparation of myocardial ischemia and reperfusion injury resistance medicines

The invention discloses an application of a Morindae officinalis extract product and Morindae officinalis oligosaccharide 6 glycan in the preparation of medicines for resisting myocardial ischemia and / or reperfusion injury and promoting therapeutic angiogenesis. The myocardial ischemia and reperfusion injury are body injuries caused by the afresh circulation establishment and the blood supply recovery during the stopping or abnormality of the myocardial blood perfusion, like ischemic and anoxic injuries. The Morindae officinalis oligosaccharide 6 glycan has a protect effect on an in-vivo rat myocardial ischemia reperfusion injury model and an in-vitro purify-cultured mouse myocardial cell reoxygenation injury model, can substantially reduces the myocardial infarction area, can mitigate the reperfusion arrhythmia, can effectively protect the form of myocardial cells, and can mitigate the injuries of anoxic reoxygenation to the myocardial cells. The therapeutic angiogenesis promotion is characterized in that the ischemic myocardial blood supply recovery and the cardiac function improvement are realized by increasing the functional coronary arterial tree or coronary collateral through some irradiations comprising the treatment effects of some medicines.
Owner:ZHENGZHOU UNIV

Apparatus and method for determining a fractional flow reserve

The present invention relates to an apparatus (26) and a method for determining a fractional flow reserve. For this purpose, a new personalized hyperemic boundary condition model is provided. The personalized hyperemic boundary condition model is used to condition a parametric model for a simulation of a blood flow in a coronary tree (34) of a human subject. As a basis for the personalized hyperemic boundary condition 5 model, a predefined hyperemic boundary condition model is used, which represents empirical derived hyperemic boundary condition parameters. However, these empirical hyperemic boundary condition parameters are not specific for a human subject under examination. In order to achieve a specification of the respective predefined hyperemic boundary condition model, specific human subject features are derived from a volumetric image of the coronary 10 tree of the human subject. These features are used to adjust the predefined hyperemic boundary condition model resulting in a personalized hyperemic boundary condition model. As an effect, a flow simulation using the parametric model conditioned by the personalized hyperemic boundary condition model. As an effect, a flow simulation using the parametric model conditioned by the personalized hypefcmtc boundary condition model improves the performance of flow simulation in order to determine an enhanced fractional flow reserve. 15
Owner:KONINKLJIJKE PHILIPS NV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products